Patents by Inventor Lynn Harrison

Lynn Harrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240094619
    Abstract: A thermographic substrate assembly includes a colorant and a flexible substrate.
    Type: Application
    Filed: October 2, 2023
    Publication date: March 21, 2024
    Applicant: International Imaging Materials, Inc.
    Inventors: Daniel Jude Harrison, Jennifer Lynn Eskra, John Richard Przybylo
  • Patent number: 10758910
    Abstract: A horizontal grinding machine includes a frame, a feed hopper that receives material to be processed, and a feed conveyor that moves material to be processed in a processing direction. A grinding cylinder rotates about a generally horizontal grinding axis. A feed roller assembly is mounted on the frame at the rear end of the feed hopper and in front of the grinding cylinder. The feed roller assembly includes a feed roller that rotates about a generally horizontal axis in a first direction that urges the material towards the grinding cylinder and a second direction that urges the material away from the grinding cylinder. A controller is operatively connected to the feed roller and to the feed conveyor and controls the rotational speed of the feed roller and the speed of the feed conveyor to obtain a predetermined ratio of feed roller rotational speed to feed conveyor speed.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: September 1, 2020
    Assignee: Astec Industries, Inc.
    Inventors: David Lynn Harrison, Lawrence Robert Cumming, Glenn Ford Bittrolf
  • Publication number: 20170165674
    Abstract: A horizontal grinding machine includes a frame, a feed hopper that is adapted to receive material to be processed and a feed conveyor that is associated with the feed hopper and adapted to move material to be processed in a processing direction. The grinding machine includes a grinding cylinder that is adapted to rotate about a generally horizontal grinding axis and a feed roller assembly that is mounted on the frame at the rear end of the feed hopper and in front of the grinding cylinder. The feed roller assembly includes a feed roller that is adapted to rotate about a generally horizontal axis in a first direction that urges the material towards the grinding cylinder and a second direction that urges the material away from the grinding cylinder.
    Type: Application
    Filed: December 8, 2016
    Publication date: June 15, 2017
    Applicant: Astec Industries, Inc.
    Inventors: David Lynn Harrison, Lawrence Robert Cumming, Glenn Ford Bittrolf
  • Publication number: 20140180718
    Abstract: Computer systems and methods relating to operating medical electronic records software application remotely using at least one mobile computing device. Also, computer systems and methods relating to operating medical practice management software applications remotely using at least one mobile computing device.
    Type: Application
    Filed: October 15, 2013
    Publication date: June 26, 2014
    Inventor: Tammy Lynn Harrison
  • Patent number: 8588765
    Abstract: Computer systems and methods relating to operating medical electronic records software application remotely using at least one mobile computing device. Also, computer systems and methods relating to operating medical practice management software applications remotely using at least one mobile computing device.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: November 19, 2013
    Inventor: Tammy Lynn Harrison
  • Patent number: 7858658
    Abstract: Compounds of Formula (I), are provided where T is CHO, COR8, or C(OH)R1R2; R1 and R2 are hydrogen, optionally substituted lower alkyl, CF3, optionally substituted alkenyl, or optionally substituted alkynyl; R3 is hydrogen or optionally substituted lower alkyl; R4 is (CF3)nalkyl, (CF3)n(substitutedalkyl), (CF3)nalkylphenyl, (CF3)nalkyl(substitutedphenyl), or (F)ncycloalkyl; n=1-3; R5 is hydrogen, halogen, CF3, diene fused to Y when Y=C, or substituted diene fused to Y when Y=C; W, Y and Z are C, CR6 or N where at least one of W, Y or Z are C; R6 is hydrogen, halogen, or optionally substituted lower alkyl; X is O, S, SO2, or NR7; R7 is hydrogen, optionally substituted lower alkyl, optionally substituted benzyl, or optionally substituted phenyl; and R8 is lower alkyl, CF3, or optionally substituted phenyl. Methods of preparing and using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are also described.
    Type: Grant
    Filed: May 5, 2009
    Date of Patent: December 28, 2010
    Assignee: Wyeth LLC
    Inventors: Anthony Frank Kreft, Lynn Resnick, Scott Christian Mayer, George Diamantidis, Derek Cecil Cole, Boyd Lynn Harrison, Minsheng Zhang, Molly Hoke, Tingzhong Wang, Rocco John Galante
  • Publication number: 20090253716
    Abstract: The present invention provides an amino-imidazolone compound of formula I Also provided are compositions and methods for the use thereof to inhibit ?-secretase (BACE) and treat ?-amyloid deposits and neurofibrillary tangles.
    Type: Application
    Filed: June 18, 2009
    Publication date: October 8, 2009
    Inventors: Michael Sotirios Malamas, James Joseph Erdei, Iwan Suwandi Gunawan, Pawel Wojciech Nowak, Boyd Lynn Harrison
  • Publication number: 20090227667
    Abstract: Compounds of Formula (I), are provided where T is CHO, COR8, or C(OH)R1R2; R1 and R2 are hydrogen, optionally substituted lower alkyl, CF3, optionally substituted alkenyl, or optionally substituted alkynyl; R3 is hydrogen or optionally substituted lower alkyl; R4 is (CF3)nalkyl, (CF3)n(substitutedalkyl), (CF3)nalkylphenyl, (CF3)nalkyl(substitutedphenyl), or (F)ncycloalkyl; n=1-3; R5 is hydrogen, halogen, CF3, diene fused to Y when Y=C, or substituted diene fused to Y when Y=C; W, Y and Z are C, CR6 or N where at least one of W, Y or Z are C; R6 is hydrogen, halogen, or optionally substituted lower alkyl; X is O, S, SO2, or NR7; R7 is hydrogen, optionally substituted lower alkyl, optionally substituted benzyl, or optionally substituted phenyl; and R8 is lower alkyl, CF3, or optionally substituted phenyl. Methods of preparing and using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are also described.
    Type: Application
    Filed: May 5, 2009
    Publication date: September 10, 2009
    Applicant: Wyeth
    Inventors: Anthony Frank Kreft, Lynn Resnick, Scott Christian Mayer, George Diamantidis, Derek Cecil Cole, Boyd Lynn Harrison, Minsheng Zhang, Molly Hoke, Tingzhong Wang, Rocco John Galante
  • Publication number: 20090221711
    Abstract: A compound of Formula (I), or pharmaceutically acceptable salts and/or hydrates or prodrugs thereof, wherein Formula (I) has the structure: is provided, wherein R1-R7 are defined herein. These compounds are useful in medicaments for treating a disease selected from the group consisting of Alzheimer's disease, amyloid angiopathy, cerebral amyloid angiopathy, systemic amyloidosis, hereditary cerebral hemorrhage with amyloidosis of the Dutch type, inclusion body myositis, mild cognitive impairment (MCI) and Down's syndrome, in a subject.
    Type: Application
    Filed: May 12, 2009
    Publication date: September 3, 2009
    Applicant: Wyeth
    Inventors: Alexander Michael Porte, Thomas Joseph Caggiano, George Diamantidis, Diane Barbara Hauze, Boyd Lynn Harrison, Molly Hoke, Anthony Kreft, Dennis M. Kubrak, Charles William Mann, Scott Mayer, Koi Michele Morris
  • Patent number: 7563796
    Abstract: The present invention provides an amino-imidazolone compound of formula I Also provided are compositions and methods for the use thereof to inhibit ?-secretase (BACE) and treat ?-amyloid deposits and neurofibrillary tangles.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: July 21, 2009
    Assignee: Wyeth
    Inventors: Michael Sotirios Malamas, James Joseph Erdei, Iwan Suwandi Gunawan, Pawel Wojciech Nowak, Boyd Lynn Harrison
  • Patent number: 7550629
    Abstract: A compound of Formula (I), or pharmaceutically acceptable salts and/or hydrates or prodrugs thereof, wherein Formula (I) has the structure: is provided, wherein R1-R7 are defined herein. These compounds are useful in medicaments for treating a disease selected from the group consisting of Alzheimer's Disease, amyloid angiopathy, cerebral amyloid angiopathy, systemic amyloidosis, hereditary cerebral hemorrhage with amyloidosis of the Dutch type, inclusion body myositis, mild cognitive impairment (MCI) and Down's syndrome, in a subject.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: June 23, 2009
    Assignee: Wyeth
    Inventors: Alexander Michael Porte, Thomas Joseph Caggiano, George Diamantidis, Diane Barbara Hauze, Boyd Lynn Harrison, Molly Hoke, Anthony Kreft, Dennis M. Kubrak, Charles William Mann, Scott Mayer, Koi Michele Morris
  • Patent number: 7547725
    Abstract: Compounds of Formula (I), are provided where T is CHO, COR8, or C(OH)R1R2; R1 and R2 are hydrogen, optionally substituted lower alkyl, CF3, optionally substituted alkenyl, or optionally substituted alkynyl; R3 is hydrogen or optionally substituted lower alkyl; R4 is (CF3)nalkyl, (CF3)n(substituted alkyl), (CF3)nalkylphenyl, (CF3)nalkyl(substituted phenyl), or (F)ncycloalkyl; n=1-3; R5 is hydrogen, halogen, CF3, diene fused to Y when Y?C, or substituted diene fused to Y when Y?C; W, Y and Z are C, CR6 or N where at least one of W, Y or Z are C; R6 is hydrogen, halogen, or optionally substituted lower alkyl; X is O, S, SO2, or NR7; R7 is hydrogen, optionally substituted lower alkyl, optionally substituted benzyl, or optionally substituted phenyl; and R8 is lower alkyl, CF3, or optionally substituted phenyl. Methods of preparing and using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are also described.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: June 16, 2009
    Assignee: Wyeth
    Inventors: Anthony Frank Kreft, Lynn Resnick, Scott Christian Mayer, George Diamantidis, Derek Cecil Cole, Boyd Lynn Harrison, Minsheng Zhang, Molly Hoke, Tingzhong Wang, Rocco John Galante
  • Publication number: 20080221193
    Abstract: The present invention relates to 3-amino chromane derivatives; to compositions containing such compounds; to methods of synthesizing such compounds; and to methods of using such compounds and compositions containing such compounds in the treatment of serotonin disorders, such as depression and anxiety.
    Type: Application
    Filed: December 21, 2007
    Publication date: September 11, 2008
    Applicant: Wyeth
    Inventors: Minsheng Zhang, Charles J. Stanton, Nicole T. Hatzenbuhler, Boyd Lynn Harrison
  • Publication number: 20080139546
    Abstract: The present invention relates to a compound of the formula: or an enantiomer, diastereomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, useful as modulators of 5-HT1A receptor activity and/or serotonin reuptake. These compounds are useful in treating nervous system disorders, such as anxiety-related disorders, cognition-related disorders, depression, schizophrenia, or sexual dysfunction and related illnesses.
    Type: Application
    Filed: September 28, 2007
    Publication date: June 12, 2008
    Applicant: Wyeth
    Inventors: Minsheng Zhang, Charles J. Stanton, Boyd Lynn Harrison, Terrance H. Andree
  • Patent number: 7300951
    Abstract: Compounds of Formula (I), are provided where T is CHO, CON, or C(OH)R1R2; R1 and R2 are hydrogen, optionally substituted lower alkyl, CF3, optionally substituted alkenyl, or optionally substituted alkynyl; R3 is hydrogen or optionally substituted lower alkyl; R4 is (CF3)nalkyl, (CF3)n(substitutedalkyl), (CF3)nalkylphenyl, (CF3)nalkyl(substitutedphenyl), or (F)ncycloalkyl; n=1-3; R5 is hydrogen, halogen, CF3, diene fused to Y when Y?C, or substituted diene fused to Y when Y?C; W, Y and Z are C, CR6 or N where at least one of W, Y or Z are C; R6 is hydrogen, halogen, or optionally substituted lower alkyl; X is O, S, SO2, or NR7; R7 is hydrogen, optionally substituted lower alkyl, optionally substituted benzyl, or optionally substituted phenyl; and R8 is lower alkyl, CF3, or optionally substituted phenyl. Methods of preparing and using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are also described.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: November 27, 2007
    Assignee: Wyeth
    Inventors: Anthony Frank Kreft, Lynn Resnick, Scott Christian Mayer, George Diamantidis, Derek Cecil Cole, Boyd Lynn Harrison, Minsheng Zhang, Molly Hoke, Tingzhong Wang, Rocco John Galante
  • Publication number: 20070268952
    Abstract: A method for calibrating a thermometer is disclosed. The thermometer comprises a primary temperature sensor for determining the temperature of a target. The thermometer also comprises a reference temperature sensor positioned proximate to the primary temperature sensor and being responsive to an extraneous temperature affecting the primary temperature sensor. One calibration method calibrates the reference temperature sensor. This calibration can utilize a non-electrically conductive liquid bath for temperature control. Another calibration method calibrates the reference temperature sensor and the primary temperature sensor.
    Type: Application
    Filed: May 19, 2006
    Publication date: November 22, 2007
    Applicant: SHERWOOD SERVICES AG
    Inventor: Lynn Harrison Scott
  • Publication number: 20070249722
    Abstract: A compound of Formula (I), or pharmaceutically acceptable salts and/or hydrates or prodrugs thereof, wherein Formula (I) has the structure: is provided, wherein R1-R7 are defined herein. These compounds are useful in medicaments for treating a disease selected from the group consisting of Alzheimer's Disease, amyloid angiopathy, cerebral amyloid angiopathy, systemic amyloidosis, hereditary cerebral hemorrhage with amyloidosis of the Dutch type, inclusion body myositis, mild cognitive impairment (MCI) and Down's syndrome, in a subject.
    Type: Application
    Filed: April 19, 2007
    Publication date: October 25, 2007
    Applicant: Wyeth
    Inventors: Alexander Michael Porte, Thomas Joseph Caggiano, George Diamantidis, Diane Barbara Hauze, Boyd Lynn Harrison, Molly Hoke, Anthony Kreft, Dennis M. Kubrak, Charles William Mann, Scott Mayer, Koi Michele Morris
  • Patent number: 7256198
    Abstract: Novel pyrimidoindolone compounds are disclosed. Methods of using the pyrimidoindolone compounds and compositions containing the compounds in the treatment and/or prevention of disease and other conditions related to inflammation, neurodegeneration, osteoarthritis and apoptosis are also disclosed.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: August 14, 2007
    Assignee: Wyeth
    Inventors: Paul Jeffrey Dollings, Arlene Joan Dietrich, Lisa Marie Havran, Chae-Koo Dan Chong, Donna Mary Huryn, Albert Jean Robichaud, Boyd Lynn Harrison, Wayne Everett Childers, Alexander A. Greenfield, James Jacob Bicksler, Vasilios Marathias
  • Patent number: 6815456
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: November 9, 2004
    Assignee: Wyeth
    Inventors: Ping Zhou, Boyd Lynn Harrison, Yanfang Li
  • Publication number: 20040198778
    Abstract: Compounds of Formula (I), 1
    Type: Application
    Filed: March 26, 2004
    Publication date: October 7, 2004
    Applicant: Wyeth
    Inventors: Anthony Frank Kreft, Lynn Resnick, Scott Christian Mayer, George Diamantidis, Derek Cecil Cole, Boyd Lynn Harrison, Minsheng Zhang, Molly Hoke, Tingzhong Wang, Rocco John Galante